Skip to results
Modify your search
NARROW
1-20 of 70
Authors: Walter Reinisch
Journal Article
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1095–1108, https://doi.org/10.1093/ibd/izae278
Published: 04 December 2024
Journal Article
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients Get access
Inflammatory Bowel Diseases, izae233, https://doi.org/10.1093/ibd/izae233
Published: 26 September 2024
Journal Article
EDITOR'S CHOICE
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition—A Prospective Multicenter Study
Inflammatory Bowel Diseases, Volume 30, Issue 1, January 2024, Pages 9–19, https://doi.org/10.1093/ibd/izad126
Published: 18 July 2023
Journal Article
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index
Inflammatory Bowel Diseases, Volume 30, Issue 3, March 2024, Pages 370–381, https://doi.org/10.1093/ibd/izad074
Published: 28 April 2023
Journal Article
Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy
Inflammatory Bowel Diseases, Volume 30, Issue 2, February 2024, Pages 311–313, https://doi.org/10.1093/ibd/izad077
Published: 26 April 2023
Journal Article
ENDOSCOPIC SCORE INTER-READER CONCORDANCE ANALYSIS FROM A PHASE 2B STUDY IN PATIENTS WITH MILD-TO-MODERATE UC
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S18–S19, https://doi.org/10.1093/ibd/izac247.036
Published: 26 January 2023
Journal Article
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 9, September 2023, Pages 1390–1398, https://doi.org/10.1093/ibd/izac231
Published: 25 November 2022
Journal Article
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn’s Disease: A Post Hoc Analysis
Inflammatory Bowel Diseases, Volume 29, Issue 8, August 2023, Pages 1263–1271, https://doi.org/10.1093/ibd/izac210
Published: 30 September 2022
Journal Article
EDITOR'S CHOICE
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1015–1023, https://doi.org/10.1093/ibd/izac168
Published: 03 August 2022
Journal Article
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 6, June 2023, Pages 875–882, https://doi.org/10.1093/ibd/izac157
Published: 26 July 2022
Journal Article
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 716–725, https://doi.org/10.1093/ibd/izac130
Published: 28 June 2022
Journal Article
EDITOR'S CHOICE
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials
Inflammatory Bowel Diseases, Volume 29, Issue 1, January 2023, Pages 1–8, https://doi.org/10.1093/ibd/izac067
Published: 02 April 2022
Journal Article
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial
Inflammatory Bowel Diseases, Volume 28, Issue 11, November 2022, Pages 1737–1745, https://doi.org/10.1093/ibd/izab361
Published: 31 January 2022
Journal Article
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
Inflammatory Bowel Diseases, Volume 28, Issue 11, November 2022, Pages 1687–1695, https://doi.org/10.1093/ibd/izab339
Published: 15 January 2022
Journal Article
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Inflammatory Bowel Diseases, Volume 28, Issue 10, October 2022, Pages 1555–1564, https://doi.org/10.1093/ibd/izab310
Published: 30 December 2021
Journal Article
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Study
Inflammatory Bowel Diseases, Volume 28, Issue 7, July 2022, Pages 1034–1044, https://doi.org/10.1093/ibd/izab215
Published: 24 August 2021
Journal Article
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 314–317, https://doi.org/10.1093/ibd/izab184
Published: 28 July 2021
Journal Article
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 234–245, https://doi.org/10.1093/ibd/izab056
Published: 20 March 2021
Journal Article
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab
Inflammatory Bowel Diseases, Volume 27, Issue 12, December 2021, Pages 1963–1967, https://doi.org/10.1093/ibd/izab026
Published: 12 February 2021
Journal Article
Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism
Inflammatory Bowel Diseases, Volume 27, Issue 11, November 2021, Pages 1773–1783, https://doi.org/10.1093/ibd/izaa337
Published: 02 January 2021
